Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.119ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.119ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.119EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.119EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.119ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.119ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.276EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.276EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.276ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.276ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.276EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.276EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.276ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.276ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.111EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.111EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.111ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.111ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.111EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.111EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.111ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.111ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.50EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-21683South Korea
B.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.50ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-15465.7Germany
B.50ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.50EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.50EHuang-EGCAGCAGTACGCACACAATC20552637626357R-15585.8China
B.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.494EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.494EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.494ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.494ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.494EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.494EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.494ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.494ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.167EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.167EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.167ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.167ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used